Last updated on June 2019

Trial Evaluating the Efficacy of Systemic Mesenchymal Stromal Cell (MSC) Injections for the Treatment of Severe and Chronic Radiotherapy-induced Abdomino-pelvic Complications (Pelvic Radiation Disease PRD) Refractory to Standard Therapy


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Radiation-induced Hemorrhagic Cystitis | Pelvic Radiation Therapy
  • Age: Between 18 - 80 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Age 18 years and <80 years;
  • Any pelvic cancerous pathology irradiated with a history of pelvic complications of grade > 2 LENT SOMA scale);
  • Absence of metastasis objectified by bone scintigraphy;
  • After failure following at least three lines of conventional treatment;
  • Good physical condition (WHO-performance status 0-1)

Exclusion Criteria:

  • Pregnancies (Pregnancy test carried out during the inclusion examination).

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.